Paris — Moderna’s Covid-19 mRNA vaccine is likely to offer protection of up to a couple of years, its CEO said on Thursday, even though more data is still needed to make a definitive assessment.

He also said his company was about to prove that its vaccine would also be effective against variants of the coronavirus seen in Britain and SA...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.